S. Chilla

Multiorgan and Renal Tropism of SARS-CoV-2

Victor G. Puelles, M. Aepfelbacher, M. Glatzel, 2020, The New England journal of medicine.

Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.

D. Busch, B. Banas, S. Segerer, 2005, Journal of the American Society of Nephrology : JASN.

Evolutionary genetics: Ambiguous role of CCR5 in Y. pestis infection

K. Pfeffer, P. Clapham, E. Williamson, 2004, Nature.

Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5‐deficient mice

R. Balling, W. Wurst, M. Kretzler, 2004, European journal of immunology.

The mCK-5 multiprobe RNase protection assay kit can yield erroneous results for the murine chemokines IP-10 and MCP-1.

H. Maier, B. Luckow, S. Chilla, 2000, Analytical biochemistry.

Microinjection of Cre recombinase protein into zygotes enables specific deletion of two eukaryotic selection cassettes and enhances the expression of a DsRed2 reporter gene in Ccr2/Ccr5 double‐deficient mice

P. Loetscher, H. Zerwes, H. Maier, 2009, Genesis.

Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves long‐term renal allograft outcome

É. Kiss, C. Schmidt, H. Gröne, 2009, European journal of immunology.

Identification of new regulatory sequences far upstream of the mouse monocyte chemoattractant protein-1 gene.

B. Luckow, D. Schlöndorff, S. Chilla, 2001, Genomics.